Androgen receptor stops tumor growth in the most common form of breast cancer
Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments. Their new preclinical study was ...
Mar 31, 2020
0
0